Figure 1
Plot demonstrating the gene expression profiles of cells with varying TP53 statuses (wild-type versus mutant) in response to Idasanutlin treatment. (a) UMAP visualization of cells treated with DMSO control (violet) and Idasanutlin (yellow) against a diverse set of cell lines before dimensionality reduction. Two distinct clusters correspond to the two experimental conditions. (b) UMAP visualization of cells treated with DMSO and Idasanutlin against a diverse set of cell lines after dimensionality reduction.

Plot demonstrating the gene expression profiles of cells with varying TP53 statuses (wild-type versus mutant) in response to Idasanutlin treatment. (a) UMAP visualization of cells treated with DMSO control (violet) and Idasanutlin (yellow) against a diverse set of cell lines before dimensionality reduction. Two distinct clusters correspond to the two experimental conditions. (b) UMAP visualization of cells treated with DMSO and Idasanutlin against a diverse set of cell lines after dimensionality reduction.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close